Leandro Vetcher

Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation.

Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY.

Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina.

Green Pacific Biologicals, Inc. develops algae biofuel technologies and produces algae biofuel. The firm also produces algae biofuel. The company was founded by Ian Burbulis, Carlos Gustavo Pesce, Wallace Marshall, Richard Yu and Leandro Vetcher on July 14, 2008 and is headquartered in San Francisco, CA.